Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Payables (2016 - 2025)

Historic Payables for Alkermes (ALKS) over the last 15 years, with Q3 2025 value amounting to $215.0 million.

  • Alkermes' Payables rose 3419.96% to $215.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.0 million, marking a year-over-year increase of 3419.96%. This contributed to the annual value of $185.3 million for FY2024, which is 2295.84% down from last year.
  • Alkermes' Payables amounted to $215.0 million in Q3 2025, which was up 3419.96% from $245.7 million recorded in Q2 2025.
  • In the past 5 years, Alkermes' Payables registered a high of $428.0 million during Q3 2021, and its lowest value of $160.2 million during Q3 2024.
  • For the 5-year period, Alkermes' Payables averaged around $235.8 million, with its median value being $215.0 million (2025).
  • As far as peak fluctuations go, Alkermes' Payables crashed by 5066.33% in 2022, and later surged by 3419.96% in 2025.
  • Over the past 5 years, Alkermes' Payables (Quarter) stood at $208.5 million in 2021, then grew by 5.56% to $220.1 million in 2022, then grew by 9.3% to $240.6 million in 2023, then dropped by 22.96% to $185.3 million in 2024, then rose by 16.0% to $215.0 million in 2025.
  • Its Payables stands at $215.0 million for Q3 2025, versus $245.7 million for Q2 2025 and $186.0 million for Q1 2025.